home > epc

European Pharmaceutical Contractor


European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.


For further information please contact:

Jonathan Smith

Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

View the digital version of EPC


Featured in this issue
Legal & Regulatory
Identification of Medicinal Products

Hidden Benefits

In mid-2016, the requirements of the Identification of Medicinal Products guidance will come into full effect. Due to their complexity, adhering to these new standards will be no mean feat – Wim Cypers at ArisGlobal tells us how to get the most our of compliance.

Legal & Regulatory
Regulatory Management

Informed Decisions

When getting to grips with the increasingly demanding regulatory environment, a holistic decision-making framework can help professionals make sense of the vast volumes of relevant data and lessen the risk of product delay. MakroCare’s Ravi Varahalu and Dr Raju K Dorisetty explain.

  Legal & Regulatory
Falsified Medicines Directive

Against the Clock

Christoph Krähenbühl of 3C Integrity warns pharma of the need to begin implementation strategies now for the EU's Falsified Medicines Directive. Despite the 2018 deadline and uncertainty surrounding the safety features provisions, some firms risk falling behind and having to withdraw their products from the European market.

Edited by
Dr Graham Hughes,
Consultant in
Published quarterly in
March, June,
September and December

Banner of ESMO.EPC on Samedan
Banner of Bioclinica.EPE on Samedan
Industry Events

ISPE Europe Annual Conference

4-7 May 2015, Steigenberger Airport Hotel, Frankfurt, Germany

The 2015 ISPE Europe Annual Conference – Driving Effectiveness in Pharmaceutical Operations with Integrated Quality will bring together pharmaceutical, regulatory and technology experts from around the world.
More info >>

News and Press Releases

New Book by Industry Thought Leaders Advocates for Re Engineering Clinical Trials

ICON plc, a global provider of drug and development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the release of the book "Re-Engineering Clinical Trials."
More info >>

air transport logo


White Papers

How To Increase Efficiency, Customer Satisfaction and Reduce Cost

AC Labels

A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement